Flagship V VentureLabs Rx Fund, L.P.
SEC CIK 1724939 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | 10% | 10.92M | — | $2.53M | 1 | 2023-06-06 | 2023-06-06 |
Most active insiders at SANA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PATEL DHAVALKUMAR DHIRAJLAL | EVP, CSO | — | — |
| 2 | Harr Steve | Pres, CEO, Dir | — | — |
| 3 | Wyrick Susan D. | See Remarks | — | — |
| 4 | Bishop Hans Edgar | Dir | — | — |
Flagship V VentureLabs Rx Fund, L.P. made no open-market trades at SANA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-06-08 | 2023-06-06+ | SANA | Sana Biotechnology, Inc. | Flagship V VentureLabs Rx Fund, L.P. | 10% | S - Sale | $6.28 | -403.8K | 10.92M | -4% | -$2.53M |
Purchase Sale Sale after option exercise All abbreviations